US Stock MarketDetailed Quotes

REGN Regeneron Pharmaceuticals

Watchlist
  • 896.820
  • +2.830+0.32%
Close Apr 19 16:00 ET
  • 896.820
  • 0.0000.00%
Post 16:20 ET
98.44BMarket Cap25.79P/E (TTM)

Regeneron Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-8.39%4.59B
-36.64%1.09B
77.18%1.11B
81.15%1.02B
-34.93%1.37B
-29.18%5.01B
-27.51%1.72B
-81.58%628.9M
-9.94%564.4M
214.39%2.1B
Net income from continuing operations
-8.87%3.95B
-3.13%1.16B
-23.40%1.01B
13.65%968.4M
-15.99%817.8M
-46.28%4.34B
-46.29%1.2B
-19.39%1.32B
-72.50%852.1M
-12.71%973.5M
Operating gains losses
623.91%266.4M
27.92%-58.1M
150.10%127M
-81.43%30.9M
-18.53%166.6M
109.51%36.8M
-158.58%-80.6M
-965.19%-253.5M
140.63%166.4M
241.62%204.5M
Depreciation and amortization
23.32%421M
12.89%113M
13.82%105.4M
38.58%103.1M
33.92%99.5M
19.29%341.4M
34.36%100.1M
26.50%92.6M
4.64%74.4M
10.24%74.3M
Deferred tax
-12.25%-837.8M
-2.36%-286.3M
-46.67%-125.7M
-34.17%-209.3M
3.78%-216.5M
-407.41%-746.4M
-35.84%-279.7M
-1,324.29%-85.7M
-474.10%-156M
-2,327.72%-225M
Other non cash items
-100.02%-100K
-110.36%-17.5M
-119.44%-11.8M
-96.55%8.6M
-75.56%20.6M
-1.00%563M
-44.46%169M
-15.46%60.7M
51.92%249M
193.73%84.3M
Change In working capital
61.32%-94.1M
-116.07%-61.4M
71.18%-192.3M
89.59%-81.3M
-70.74%240.9M
87.30%-243.3M
207.48%382M
-145.60%-667.2M
68.56%-781.3M
252.61%823.2M
-Change in receivables
-147.87%-338.8M
-137.66%-82.7M
-19.80%-463.5M
99.16%-2.7M
-82.46%210.1M
136.72%707.8M
137.57%219.6M
-125.11%-386.9M
88.59%-322.4M
2,154.03%1.2B
-Change in inventory
60.99%-271.7M
67.22%-47.3M
65.46%-77.2M
58.18%-100.4M
47.18%-46.8M
-40.91%-696.5M
11.85%-144.3M
-104.86%-223.5M
-867.09%-240.1M
64.95%-88.6M
-Change in prepaid assets
19.18%-120.1M
778.61%164.3M
-327.31%-275.5M
98.60%-3.4M
87.72%-5.5M
38.26%-148.6M
-75.43%18.7M
410.77%121.2M
-6.98%-243.7M
10.40%-44.8M
-Change in payables and accrued expense
532.51%598.6M
-139.90%-138.7M
460.95%578.6M
152.72%39.7M
147.52%119M
-115.98%-138.4M
-4.95%347.6M
-309.00%-160.3M
-116.43%-75.3M
-621.61%-250.4M
-Change in other working capital
16.98%37.9M
172.15%43M
355.93%45.3M
-114.47%-14.5M
-477.89%-35.9M
126.96%32.4M
-21.63%-59.6M
-176.56%-17.7M
27.16%100.2M
106.62%9.5M
Cash from discontinued investing activities
Operating cash flow
-8.39%4.59B
-36.64%1.09B
77.18%1.11B
81.15%1.02B
-34.93%1.37B
-29.18%5.01B
-27.51%1.72B
-81.58%628.9M
-9.94%564.4M
214.39%2.1B
Investing cash flow
Cash flow from continuing investing activities
15.84%-3.19B
96.44%-66.2M
-358.09%-496.3M
-476.69%-2.39B
86.18%-235.7M
29.72%-3.78B
7.70%-1.86B
107.89%192.3M
-429.01%-413.9M
-61.03%-1.71B
Capital expenditure reported
-21.78%-718.6M
-65.18%-251.4M
-23.51%-176M
26.43%-113M
-25.67%-178.2M
-6.92%-590.1M
1.74%-152.2M
-6.98%-142.5M
-3.43%-153.6M
-22.98%-141.8M
Net intangibles purchase and sale
79.76%-207.8M
37.90%-62.1M
97.42%-23.9M
---20.9M
---100.9M
---1.03B
---100M
---926.8M
--0
--0
Net business purchase and sale
76.16%-54.9M
---3.8M
----
----
----
---230.3M
--0
----
----
----
Net investment purchase and sale
-13.75%-2.2B
115.64%251.1M
-119.44%-245.3M
-7,410.00%-2.25B
102.78%43.4M
59.91%-1.94B
13.58%-1.61B
154.72%1.26B
-110.94%-30M
-65.68%-1.56B
Cash from discontinued investing activities
Investing cash flow
15.84%-3.19B
96.44%-66.2M
-358.09%-496.3M
-476.69%-2.39B
86.18%-235.7M
29.72%-3.78B
7.70%-1.86B
107.89%192.3M
-429.01%-413.9M
-61.03%-1.71B
Financing cash flow
Cash flow from continuing financing activities
-77.41%-1.79B
-80.17%-446.1M
43.82%-407.3M
-507.52%-614.2M
-598.45%-322.5M
-0.32%-1.01B
72.69%-247.6M
-288.12%-725M
14.47%-101.1M
117.66%64.7M
Net common stock issuance
-77.41%-1.79B
-80.17%-446.1M
43.82%-407.3M
-507.52%-614.2M
-598.45%-322.5M
-0.32%-1.01B
72.69%-247.6M
-288.12%-725M
14.47%-101.1M
117.66%64.7M
Cash from discontinued financing activities
Financing cash flow
-77.41%-1.79B
-80.17%-446.1M
43.82%-407.3M
-507.52%-614.2M
-598.45%-322.5M
-0.32%-1.01B
72.69%-247.6M
-288.12%-725M
14.47%-101.1M
117.66%64.7M
Net cash flow
Beginning cash position
7.64%3.12B
-38.36%2.16B
-42.80%1.95B
16.96%3.93B
7.64%3.12B
31.30%2.9B
1.74%3.5B
63.51%3.41B
131.61%3.36B
31.30%2.9B
Current changes in cash
-272.25%-381.2M
249.82%577.4M
119.02%210.7M
-4,105.47%-1.98B
75.54%809.4M
-67.96%221.3M
29.52%-385.4M
-92.93%96.2M
-92.21%49.4M
160.92%461.1M
Effect of exchange rate changes
---400K
--200K
---200K
----
----
--0
--0
--0
----
----
End cash Position
-12.23%2.74B
-12.23%2.74B
-38.36%2.16B
-42.80%1.95B
16.96%3.93B
7.64%3.12B
7.64%3.12B
1.74%3.5B
63.51%3.41B
131.61%3.36B
Free cash flow
7.93%3.67B
-47.11%776.2M
307.63%914.4M
116.29%888.5M
-44.46%1.09B
-47.96%3.4B
-33.82%1.47B
-113.43%-440.4M
-14.09%410.8M
254.28%1.96B
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
--
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -8.39%4.59B-36.64%1.09B77.18%1.11B81.15%1.02B-34.93%1.37B-29.18%5.01B-27.51%1.72B-81.58%628.9M-9.94%564.4M214.39%2.1B
Net income from continuing operations -8.87%3.95B-3.13%1.16B-23.40%1.01B13.65%968.4M-15.99%817.8M-46.28%4.34B-46.29%1.2B-19.39%1.32B-72.50%852.1M-12.71%973.5M
Operating gains losses 623.91%266.4M27.92%-58.1M150.10%127M-81.43%30.9M-18.53%166.6M109.51%36.8M-158.58%-80.6M-965.19%-253.5M140.63%166.4M241.62%204.5M
Depreciation and amortization 23.32%421M12.89%113M13.82%105.4M38.58%103.1M33.92%99.5M19.29%341.4M34.36%100.1M26.50%92.6M4.64%74.4M10.24%74.3M
Deferred tax -12.25%-837.8M-2.36%-286.3M-46.67%-125.7M-34.17%-209.3M3.78%-216.5M-407.41%-746.4M-35.84%-279.7M-1,324.29%-85.7M-474.10%-156M-2,327.72%-225M
Other non cash items -100.02%-100K-110.36%-17.5M-119.44%-11.8M-96.55%8.6M-75.56%20.6M-1.00%563M-44.46%169M-15.46%60.7M51.92%249M193.73%84.3M
Change In working capital 61.32%-94.1M-116.07%-61.4M71.18%-192.3M89.59%-81.3M-70.74%240.9M87.30%-243.3M207.48%382M-145.60%-667.2M68.56%-781.3M252.61%823.2M
-Change in receivables -147.87%-338.8M-137.66%-82.7M-19.80%-463.5M99.16%-2.7M-82.46%210.1M136.72%707.8M137.57%219.6M-125.11%-386.9M88.59%-322.4M2,154.03%1.2B
-Change in inventory 60.99%-271.7M67.22%-47.3M65.46%-77.2M58.18%-100.4M47.18%-46.8M-40.91%-696.5M11.85%-144.3M-104.86%-223.5M-867.09%-240.1M64.95%-88.6M
-Change in prepaid assets 19.18%-120.1M778.61%164.3M-327.31%-275.5M98.60%-3.4M87.72%-5.5M38.26%-148.6M-75.43%18.7M410.77%121.2M-6.98%-243.7M10.40%-44.8M
-Change in payables and accrued expense 532.51%598.6M-139.90%-138.7M460.95%578.6M152.72%39.7M147.52%119M-115.98%-138.4M-4.95%347.6M-309.00%-160.3M-116.43%-75.3M-621.61%-250.4M
-Change in other working capital 16.98%37.9M172.15%43M355.93%45.3M-114.47%-14.5M-477.89%-35.9M126.96%32.4M-21.63%-59.6M-176.56%-17.7M27.16%100.2M106.62%9.5M
Cash from discontinued investing activities
Operating cash flow -8.39%4.59B-36.64%1.09B77.18%1.11B81.15%1.02B-34.93%1.37B-29.18%5.01B-27.51%1.72B-81.58%628.9M-9.94%564.4M214.39%2.1B
Investing cash flow
Cash flow from continuing investing activities 15.84%-3.19B96.44%-66.2M-358.09%-496.3M-476.69%-2.39B86.18%-235.7M29.72%-3.78B7.70%-1.86B107.89%192.3M-429.01%-413.9M-61.03%-1.71B
Capital expenditure reported -21.78%-718.6M-65.18%-251.4M-23.51%-176M26.43%-113M-25.67%-178.2M-6.92%-590.1M1.74%-152.2M-6.98%-142.5M-3.43%-153.6M-22.98%-141.8M
Net intangibles purchase and sale 79.76%-207.8M37.90%-62.1M97.42%-23.9M---20.9M---100.9M---1.03B---100M---926.8M--0--0
Net business purchase and sale 76.16%-54.9M---3.8M---------------230.3M--0------------
Net investment purchase and sale -13.75%-2.2B115.64%251.1M-119.44%-245.3M-7,410.00%-2.25B102.78%43.4M59.91%-1.94B13.58%-1.61B154.72%1.26B-110.94%-30M-65.68%-1.56B
Cash from discontinued investing activities
Investing cash flow 15.84%-3.19B96.44%-66.2M-358.09%-496.3M-476.69%-2.39B86.18%-235.7M29.72%-3.78B7.70%-1.86B107.89%192.3M-429.01%-413.9M-61.03%-1.71B
Financing cash flow
Cash flow from continuing financing activities -77.41%-1.79B-80.17%-446.1M43.82%-407.3M-507.52%-614.2M-598.45%-322.5M-0.32%-1.01B72.69%-247.6M-288.12%-725M14.47%-101.1M117.66%64.7M
Net common stock issuance -77.41%-1.79B-80.17%-446.1M43.82%-407.3M-507.52%-614.2M-598.45%-322.5M-0.32%-1.01B72.69%-247.6M-288.12%-725M14.47%-101.1M117.66%64.7M
Cash from discontinued financing activities
Financing cash flow -77.41%-1.79B-80.17%-446.1M43.82%-407.3M-507.52%-614.2M-598.45%-322.5M-0.32%-1.01B72.69%-247.6M-288.12%-725M14.47%-101.1M117.66%64.7M
Net cash flow
Beginning cash position 7.64%3.12B-38.36%2.16B-42.80%1.95B16.96%3.93B7.64%3.12B31.30%2.9B1.74%3.5B63.51%3.41B131.61%3.36B31.30%2.9B
Current changes in cash -272.25%-381.2M249.82%577.4M119.02%210.7M-4,105.47%-1.98B75.54%809.4M-67.96%221.3M29.52%-385.4M-92.93%96.2M-92.21%49.4M160.92%461.1M
Effect of exchange rate changes ---400K--200K---200K----------0--0--0--------
End cash Position -12.23%2.74B-12.23%2.74B-38.36%2.16B-42.80%1.95B16.96%3.93B7.64%3.12B7.64%3.12B1.74%3.5B63.51%3.41B131.61%3.36B
Free cash flow 7.93%3.67B-47.11%776.2M307.63%914.4M116.29%888.5M-44.46%1.09B-47.96%3.4B-33.82%1.47B-113.43%-440.4M-14.09%410.8M254.28%1.96B
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion------------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg